Trade Windtree Therapeutics, Inc. - WINT CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.1570 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023512% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.00129% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 0.01 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 0.0865 |
| Open | 4.325 |
| 1-Year Change | 1135.36% |
| Day's Range | 4.0065 - 4.4165 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Feb 21, 2025 | 4.2665 | -0.0585 | -1.35% | 4.3250 | 4.5665 | 3.8565 |
| Feb 20, 2025 | 0.0865 | -0.0100 | -10.36% | 0.0965 | 0.0965 | 0.0865 |
| Feb 19, 2025 | 0.0974 | -0.0052 | -5.07% | 0.1026 | 0.1046 | 0.0966 |
| Feb 18, 2025 | 0.1040 | 0.0018 | 1.76% | 0.1022 | 0.1173 | 0.1015 |
| Feb 14, 2025 | 0.1335 | -0.0073 | -5.18% | 0.1408 | 0.1433 | 0.1265 |
| Feb 13, 2025 | 0.1460 | 0.0000 | 0.00% | 0.1460 | 0.1572 | 0.1365 |
| Feb 12, 2025 | 0.1679 | -0.0126 | -6.98% | 0.1805 | 0.2022 | 0.1465 |
| Feb 11, 2025 | 0.1537 | 0.0248 | 19.24% | 0.1289 | 0.1788 | 0.1199 |
| Feb 10, 2025 | 0.1339 | 0.0238 | 21.62% | 0.1101 | 0.1418 | 0.1101 |
| Feb 7, 2025 | 0.1132 | -0.0053 | -4.47% | 0.1185 | 0.1190 | 0.1115 |
| Feb 6, 2025 | 0.1191 | 0.0005 | 0.42% | 0.1186 | 0.1345 | 0.1112 |
| Feb 5, 2025 | 0.1194 | 0.0081 | 7.28% | 0.1113 | 0.1287 | 0.1020 |
| Feb 4, 2025 | 0.1119 | -0.0039 | -3.37% | 0.1158 | 0.1368 | 0.0978 |
| Feb 3, 2025 | 0.1206 | -0.0039 | -3.13% | 0.1245 | 0.1260 | 0.1165 |
| Jan 31, 2025 | 0.1245 | -0.0045 | -3.49% | 0.1290 | 0.1320 | 0.1234 |
| Jan 30, 2025 | 0.1289 | -0.0071 | -5.22% | 0.1360 | 0.1370 | 0.1289 |
| Jan 29, 2025 | 0.1353 | 0.0061 | 4.72% | 0.1292 | 0.1457 | 0.1215 |
| Jan 28, 2025 | 0.1357 | -0.0131 | -8.80% | 0.1488 | 0.1494 | 0.1338 |
| Jan 27, 2025 | 0.1535 | -0.0024 | -1.54% | 0.1559 | 0.1609 | 0.1510 |
| Jan 24, 2025 | 0.1675 | -0.0295 | -14.97% | 0.1970 | 0.3254 | 0.1628 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Windtree Therapeutics Inc. Company profile
About Windtree Therapeutics Inc
Windtree Therapeutics, Inc. is a clinical-stage biopharmaceutical and medical device company. The Company’s development programs are primarily focused on the treatment of acute cardiovascular and acute pulmonary diseases. The Company’s cardiovascular programs includes Istaroxime (Early Cardiogenic Shock), Istaroxime (acute heart failure), Rostafuroxin and Oral SERCA2a Activators. Its Pulmonary Programs include Lyophilized KL4 Surfactant and AEROSURF (aerosolized KL4 surfactant based on Aerosol Delivery System technology). The Company’s subsidiaries Discovery Laboratories, Inc., CVie Investments Limited and CVie Therapeutics Limited.
Financial summary
BRIEF: For the nine months ended 30 September 2021, Windtree Therapeutics Inc revenues was not reported. Net loss increased from $25.1M to $54.6M. Higher net loss reflects Research and development - Balancing val increase of 8% to $11.1M (expense), Stock-based Compensation in R and D increase of 39% to $2.3M (expense), Stock-based Compensation in SGA increase of 21% to $3.4M (expense).
Equity composition
Common Stock $.015 Par, 04/11, 50M auth., 13,822,000 issd., less 21,000 shs. in Treas. @ $3.1M. Insiders own 1.88%. *NOTE: 12/97 Name changed from Ansan Pharmaceuticals; FY'00 Qs are restated. *2/05, PO 5.06M shares @ $5.75 by SG Cowen & Co., LLC. 12/10, 1-for-15 reverse split. 01/06, 1-for-14 reverse stock split
| Industry: | Biotechnology & Medical Research (NEC) |
2600 Kelly Rd Ste 100
WARRINGTON
PENNSYLVANIA 18976-3652
US
News
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025
Ripple XRP price prediction: Third-party price target
Discover the ripple (XRP) price predictions for 2025 and beyond, with analyst price targets and CFDs trading strategies on Capital.com
15:29, 6 February 2025
Apple (AAPL) stock price forecast: third-party price target
We looked at the forecasts for Apple stock in 10 years to see where the price would likely be at that point and the challenges the company could face. Read more.
11:22, 6 February 2025
FARTCOIN price prediction: Third-party price target
Read our FARTCOIN price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:18, 29 January 2025
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025People also watch
Still looking for a broker you can trust?
Join the 690,000+ traders worldwide that chose to trade with Capital.com